Keywords: Genentech, Biogen, GlaxoSmithKline, Genmab, Arzerra, Rituxan

Genentech and Biogen sue GlaxoSmithKline and Genmab over Arzerra patent

Article | 26 March 2010

Print This

US biotechnology giant Genentech, a wholly-owned subsidiary of Switzerland’s Roche, and Biogen Idec have filed a declaratory relief complaint ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in